Cibus, Inc. (CBUS)
NASDAQ: CBUS · Real-Time Price · USD
1.290
-0.110 (-7.86%)
At close: Jun 5, 2026, 4:00 PM EDT
1.310
+0.020 (1.55%)
After-hours: Jun 5, 2026, 6:35 PM EDT
Cibus Revenue
Cibus had revenue of $1.68M in the quarter ending March 31, 2026, with 62.57% growth. This brings the company's revenue in the last twelve months to $4.29M, down -9.79% year-over-year. In the year 2025, Cibus had annual revenue of $3.64M, down -14.62%.
Revenue (ttm)
$4.29M
Revenue Growth
-9.79%
P/S Ratio
26.83
Revenue / Employee
$30,839
Employees
118
Market Cap
98.41M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.64M | -623.00K | -14.62% |
| Dec 31, 2024 | 4.26M | 2.45M | 134.56% |
| Dec 31, 2023 | 1.82M | 1.66M | 1,057.32% |
| Dec 31, 2022 | 157.00K | -25.83M | -99.40% |
| Dec 31, 2021 | 25.99M | 2.14M | 8.96% |
| Dec 31, 2020 | 23.85M | 16.56M | 226.91% |
| Dec 31, 2019 | 7.30M | 7.06M | 2,991.53% |
| Dec 31, 2018 | 236.00K | -272.00K | -53.54% |
| Dec 31, 2017 | 508.00K | 109.00K | 27.32% |
| Dec 31, 2016 | 399.00K | -873.00K | -68.63% |
| Dec 31, 2015 | 1.27M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Verrica Pharmaceuticals | 37.16M |
| Seer, Inc. | 16.58M |
| Pyxis Oncology | 13.86M |
| Coya Therapeutics | 7.94M |
| NeOnc Technologies Holdings | 39.99K |
CBUS News
- 3 days ago - Cibus Transcript: AGM 2026 - Transcripts
- 21 days ago - Cibus files $200M mixed securities shelf - TheFly
- 21 days ago - Cibus Registration statement: Registration filing - Filings
- 22 days ago - Cibus Earnings Call Transcript: Q1 2026 - Transcripts
- 22 days ago - Cibus Earnings release: Q1 2026 - Filings
- 22 days ago - Cibus Quarterly report: Q1 2026 - Filings
- 22 days ago - Cibus Reports First Quarter Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - Cibus transfers gene-edited materials for herbicide tolerance in rice to Interoc - TheFly